Cover Image
Market Research Report
Product code 
981970

Europe Autoinjectors Market By Type, By Application, By End Use, By Country, Industry Analysis and Forecast, 2020 - 2026

Published: | KBV Research | 97 Pages | Delivery time: 1-2 business days

Price

Back to Top
Europe Autoinjectors Market By Type, By Application, By End Use, By Country, Industry Analysis and Forecast, 2020 - 2026
Published: December 31, 2020
KBV Research
Content info: 97 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The Europe Autoinjectors Market would witness market growth of 17.1% CAGR during the forecast period (2020-2026).

Auto-injectors have numerous advantages like they lessen phobia and anxiety related to needles, decrease chances of a needle stuck incidences, keep the consistency of dose precision, and also help with better efficiency, which, in turn, support growth. Drug delivery by using an auto-injector is more controlled than manual injection.

The administration site of any drug is chosen on the basis of the nature of the drug; however, it is usually administered intramuscularly. Autoinjectors, if compared to syringes, are less painful, thus demand is increasing. Though, the availability of substitutes like oral tablets may obstruct growth.

In a reasonably short time period, the market for self-injection devices has full-fledged into a conspicuous and promising segment in the pharmaceutical industry. Autoinjectors are one such device that has witnessed amplified adoption among patients, particularly for the treatment of emergency situations like anaphylactic shocks. As per the developers, these devices are quite easier to use as compared to parenteral drug delivery systems and have incorporated needle-safety features. It has been proved that the autoinjectors have resolved a number of issues faced by patients such as injection-related tolerability.

Based on Type, the market is segmented into Disposable autoinjectors and Reusable autoinjectors. Based on Application, the market is segmented into Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis and other Applications. Based on End Use, the market is segmented into Hospitals & Clinics and Home care settings. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eli Lilly and Company, GlaxoSmithKline PLC (GSK), Merck Group, Sanofi S.A., Becton, Dickinson and Company, Teva Pharmaceuticals Industries Ltd., Amgen, Inc., Ypsomed AG, AbbVie, Inc. and Biogen, Inc.

Scope of the Study

Market Segments covered in the Report:

By Type

  • Disposable autoinjectors
  • Reusable autoinjectors

By Application

  • Anaphylaxis
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Other Applications

By End Use

  • Hospitals & Clinics
  • Home care settings

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled

  • Eli Lilly and Company
  • GlaxoSmithKline PLC (GSK)
  • Merck Group
  • Sanofi S.A.
  • Becton, Dickinson and Company
  • Teva Pharmaceuticals Industries Ltd.
  • Amgen, Inc.
  • Ypsomed AG
  • AbbVie, Inc.
  • Biogen, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Autoinjectors Market, by Type
    • 1.4.2 Europe Autoinjectors Market, by Application
    • 1.4.3 Europe Autoinjectors Market, by End Use
    • 1.4.4 Europe Autoinjectors Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Geographical Expansions
    • 3.2.4 Approvals
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
    • 3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, May - 2020, Nov) Leading Players

Chapter 4. Europe Autoinjectors Market by Type

  • 4.1 Europe Disposable autoinjectors Market by Country
  • 4.2 Europe Reusable autoinjectors Market by Country

Chapter 5. Europe Autoinjectors Market by Application

  • 5.1 Europe Anaphylaxis Market by Country
  • 5.2 Europe Rheumatoid Arthritis Market by Country
  • 5.3 Europe Multiple Sclerosis Market by Country
  • 5.4 Europe Other Application Market by Country

Chapter 6. Europe Autoinjectors Market by End Use

  • 6.1 Europe Hospitals & Clinics Autoinjectors Market by Country
  • 6.2 Europe Home care settings Autoinjectors Market by Country

Chapter 7. Europe Autoinjectors Market by Country

  • 7.1 Germany Autoinjectors Market
    • 7.1.1 Germany Autoinjectors Market by Type
    • 7.1.2 Germany Autoinjectors Market by Application
    • 7.1.3 Germany Autoinjectors Market by End Use
  • 7.2 UK Autoinjectors Market
    • 7.2.1 UK Autoinjectors Market by Type
    • 7.2.2 UK Autoinjectors Market by Application
    • 7.2.3 UK Autoinjectors Market by End Use
  • 7.3 France Autoinjectors Market
    • 7.3.1 France Autoinjectors Market by Type
    • 7.3.2 France Autoinjectors Market by Application
    • 7.3.3 France Autoinjectors Market by End Use
  • 7.4 Russia Autoinjectors Market
    • 7.4.1 Russia Autoinjectors Market by Type
    • 7.4.2 Russia Autoinjectors Market by Application
    • 7.4.3 Russia Autoinjectors Market by End Use
  • 7.5 Spain Autoinjectors Market
    • 7.5.1 Spain Autoinjectors Market by Type
    • 7.5.2 Spain Autoinjectors Market by Application
    • 7.5.3 Spain Autoinjectors Market by End Use
  • 7.6 Italy Autoinjectors Market
    • 7.6.1 Italy Autoinjectors Market by Type
    • 7.6.2 Italy Autoinjectors Market by Application
    • 7.6.3 Italy Autoinjectors Market by End Use
  • 7.7 Rest of Europe Autoinjectors Market
    • 7.7.1 Rest of Europe Autoinjectors Market by Type
    • 7.7.2 Rest of Europe Autoinjectors Market by Application
    • 7.7.3 Rest of Europe Autoinjectors Market by End Use

Chapter 8. Company Profiles

  • 8.1 Eli Lilly and Company
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Partnerships, Collaborations, and Agreements:
      • 8.1.5.2 Geographical Expansions:
  • 8.2 GlaxoSmithKline PLC (GSK)
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.1 Recent strategies and developments:
      • 8.2.1.1 Approvals:
  • 8.3 Merck Group
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expense
  • 8.4 Sanofi S.A.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expense
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Partnerships, Collaborations, and Agreements:
      • 8.4.5.2 Approvals:
      • 8.4.5.3 Product Launches and Product Expansions:
  • 8.5 Becton, Dickinson and Company
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research & Development Expense
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Partnerships, Collaborations, and Agreements:
      • 8.5.5.2 Product Launches and Product Expansions:
  • 8.6 Teva Pharmaceutical Industries Ltd.
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Regional Analysis
    • 8.6.4 Research & Development Expenses
    • 8.6.5 Recent strategies and developments:
      • 8.6.5.1 Partnerships, Collaborations, and Agreements:
      • 8.6.5.2 Product Launches and Product Expansions:
      • 8.6.5.3 Approvals:
  • 8.7 Amgen, Inc.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Research & Development Expense
    • 8.7.4 Recent strategies and developments:
      • 8.7.4.1 Product Launches and Product Expansions:
  • 8.8 Ypsomed AG
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental and Regional Analysis
    • 8.8.4 Research & Development Expense
  • 8.9 AbbVie, Inc.
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Regional Analysis
    • 8.9.4 Research & Development Expenses
    • 8.9.5 Recent strategies and developments:
      • 8.9.5.1 Partnerships, Collaborations, and Agreements:
  • 8.10. Biogen, Inc.
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Regional Analysis
    • 8.10.4 Research & Development Expenses
    • 8.10.5 Recent strategies and developments:
      • 8.10.5.1 Partnerships, Collaborations, and Agreements:

LIST OF TABLES

  • TABLE 1 EUROPE AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 2 EUROPE AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS- AUTO-INJECTORS MARKET
  • TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS- AUTO-INJECTORS MARKET
  • TABLE 5 GEOGRAPHICAL EXPANSIONS- AUTO-INJECTORS MARKET
  • TABLE 6 APPROVALS- AUTO-INJECTORS MARKET
  • TABLE 7 EUROPE AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 8 EUROPE AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 9 EUROPE DISPOSABLE AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 10 EUROPE DISPOSABLE AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 11 EUROPE REUSABLE AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 12 EUROPE REUSABLE AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 13 EUROPE AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 14 EUROPE AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 15 EUROPE ANAPHYLAXIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 16 EUROPE ANAPHYLAXIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 17 EUROPE RHEUMATOID ARTHRITIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 18 EUROPE RHEUMATOID ARTHRITIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 19 EUROPE MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 20 EUROPE MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 21 EUROPE OTHER APPLICATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 22 EUROPE OTHER APPLICATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 23 EUROPE AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 24 EUROPE AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 25 EUROPE HOSPITALS & CLINICS AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 26 EUROPE HOSPITALS & CLINICS AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 27 EUROPE HOME CARE SETTINGS AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 28 EUROPE HOME CARE SETTINGS AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 29 EUROPE AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 30 EUROPE AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 31 GERMANY AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 32 GERMANY AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 33 GERMANY AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 34 GERMANY AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 35 GERMANY AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 36 GERMANY AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 37 GERMANY AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 38 GERMANY AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 39 UK AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 40 UK AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 41 UK AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 42 UK AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 43 UK AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 44 UK AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 45 UK AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 46 UK AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 47 FRANCE AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 48 FRANCE AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 49 FRANCE AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 50 FRANCE AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 51 FRANCE AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 52 FRANCE AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 53 FRANCE AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 54 FRANCE AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 55 RUSSIA AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 56 RUSSIA AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 57 RUSSIA AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 58 RUSSIA AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 59 RUSSIA AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 60 RUSSIA AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 61 RUSSIA AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 62 RUSSIA AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 63 SPAIN AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 64 SPAIN AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 65 SPAIN AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 66 SPAIN AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 67 SPAIN AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 68 SPAIN AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 69 SPAIN AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 70 SPAIN AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 71 ITALY AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 72 ITALY AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 73 ITALY AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 74 ITALY AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 75 ITALY AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 76 ITALY AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 77 ITALY AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 78 ITALY AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 79 REST OF EUROPE AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 80 REST OF EUROPE AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 81 REST OF EUROPE AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 82 REST OF EUROPE AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 83 REST OF EUROPE AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 84 REST OF EUROPE AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 85 REST OF EUROPE AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 86 REST OF EUROPE AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 87 KEY INFORMATION - ELI LILLY AND COMPANY
  • TABLE 88 KEY INFORMATION - GLAXOSMITHKLINE PLC (GSK)
  • TABLE 89 KEY INFORMATION - MERCK GROUP
  • TABLE 90 KEY INFORMATION - SANOFI S.A.
  • TABLE 91 KEY INFORMATION - BECTON, DICKINSON AND COMPANY
  • TABLE 92 KEY INFORMATION - TEVA PHARMACEUTICALS INDUSTRIES LTD.
  • TABLE 93 KEY INFORMATION - AMGEN, INC.
  • TABLE 94 KEY INFORMATION --YPSOMED AG
  • TABLE 95 KEY INFORMATION - ABBVIE, INC.
  • TABLE 96 KEY INFORMATION - BIOGEN, INC.

LIST OF FIGURES

  • FIG 1 METHODOLOGY FOR THE RESEARCH
  • FIG 2 KBV CARDINAL MATRIX
  • FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
  • FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS : 2016, MAY - 2020, NOV) LEADING PLAYERS
  • FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: ELI LILLY AND COMPANY
  • FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: SANOFI S.A.
  • FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: BECTON, DICKINSON AND COMPANY
  • FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: TEVA PHARMACEUTICALS INDUSTRIES LTD.